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Research
A rising incidence of endocrine-related dis-
eases in recent decades (Damstra et al. 2002) 
has led to the suggestion that exposure to 
endocrine-modulating chemicals (so called 
endocrine disruptors) is the cause (Colborn 
et al. 1993; Waring and Harris 2005). There 
are many such chemicals in the environment 
that have estrogenic activity, and they are 
derived from a number of different poten-
tial sources. Phytoestrogens, such as genistein 
(GEN), occur naturally in food as compo-
nents of dietary plants such as legumes, len-
tils, chickpeas, soybean, cereals, fruits, and 
vegetables (Jordan et al. 1985). Industrial 
contaminants, such as bisphenol A (BPA) and 
polychlorinated biphenyls, may be present in 
the atmosphere or as by-products of industri-
ally produced materials such as plastics used 
as containers for drinks or food (Sheehan 
2000). Several organochlorine pesticides, such 
as endosulfan (EDS), also have estrogenic 
activity; exposure may occur from household 
use or from residues in treated food (Safe 
and Zacharewski 1997). Although EDS is no 
longer approved for use in many countries, 
exposure may still be possible through envi-
ronmental contamination.
To determine the risk to human health, 
attempts are being made to determine lev-
els of exposure, by measuring either specific 
compounds or classes of compounds (Dekant 
and Volkel 2008; Wolff et al. 2007) or by 
the use of bioassays (Fernandez et al. 2007; 
Rasmussen et al. 2003) to measure total estro-
genic activity present in blood, urine, or adi-
pose tissue (Soto et al. 1997). Although this is 
useful, it is also informative to determine the 
biological consequences of exposure to such 
levels. Consequently, there is much effort 
to identify suitable biomarkers of effect that 
can be used for this purpose. To this end, a 
number of in vitro assays have been designed 
that measure the proliferation of MCF-7 cells 
(E-screen) (Soto et al. 1995) or binding of 
estrogenic compounds to the ER through 
competitive binding assays, or reporter gene 
assays such as the yeast estrogen cell screen-
ing assay (Gutendorf and Westendorf 2001). 
Several in vivo mammalian assays have also 
been designed. These are based mostly on 
measurements of female rodent reproduc-
tive tissue development. Although it can be 
argued that some of these tests have physio-
logic relevance, they appear to perform rela-
tively poorly in terms of quantitation and 
sensitivity (Ashby 2003).
These approaches may be limited by 
the complexity of the effects of estrogenic 
compounds, which appear to have multiple 
mechanisms of action (Jefferson et al. 2002) 
that vary for different compounds (Frigo 
et al. 2002; Naciff et al. 2002). For example, 
estrogens may act on either or both of the 
estrogen receptors (ERα and ERβ) as ago-
nists or antagonists and in addition can elicit 
nonestrogenic effects (Fertuck et al. 2001). 
Certainly, gene expression studies of both 
uterine tissue and MCF-7 cells indicate that 
there is a diverse response to estrogen expo-
sure at the mRNA level (Buterin et al. 2006; 
Coser et al. 2003; Dip et al. 2008; Frasor 
et al. 2003). Similarly directed studies have 
led to a variety of suggested biomarkers of 
effect by measuring the expression of such 
genes in cell-based assays (Choi and Jeung 
2003). Although changes at the mRNA level 
are indicative of functional changes, it is more 
pertinent to study changes in the expres-
sion of proteins. Here, to this end, we have 
employed the use of surface-enhanced laser 
desorption/ionization time-of-flight mass 
spectrometry (SELDI-TOF MS) to determine 
proteomic changes. This technique has been 
applied to identify potential biomarkers for 
prognosis, diagnosis, and treatment of human 
diseases. It has the advantage of being rapid, 
reproducible, and quantifiable, allows direct 
sample comparison, and can analyze a wide 
range of proteins (Petricoin and Liotta 2004). 
Its use has been explored in classification and 
evaluation of treatment of breast cancer in 
patients (Carter et al. 2002; Laronga et al. 
2003; Wulfkuhle et al. 2001). 
In the present study, four compounds 
with estrogenic activity were assessed: 
17β-estradiol (E2) (the natural ligand for ER); 
GEN (a phytoestrogen); BPA (an industrial 
contaminant); and EDS (an organochlorine 
pesticide). Their effect on the protein profiles 
in four related human breast cell lines that 
vary in their ER phenotypes was determined. 
These were human breast cancer cell lines 
MCF-7 (ERα+/ERβ+) and MDA-MB-231 
(ERα‒/ERβ+) and human breast epithelial cell 
lines MCF-10F (ERα‒/ERβ+) and MCF-10A 
(ERα‒/ERβ‒), which are well documented 
for their differential expression of these recep-
tors (Fuqua et al. 1999; Girdler et al. 2001; 
Hu et al. 1998; Jiang and Jordan 1992; Tong 
et al. 2002). The objectives of this work were 
to determine how the proteome of the cell 
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Ba c k g r o u n d: There is concern about the potential risk posed by compounds with estrogen-like 
activity present in the environment. As previous studies have shown that combined exposure to such 
compounds results in dose additivity, it should be possible to assess estrogen exposure with suitable 
biomarkers of effect. 
oBjectives: Our goal was to identify candidate protein biomarkers of effect for estrogenic 
  compounds.
Me t h o d s : In the search for biomarkers, we assessed the effect of several estrogenic compounds on 
the expression profile of proteins in breast-derived cell lines varying in their estrogen receptor (ER) 
phenotype using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. We 
identified responsive proteins, after separating them by SDS-polyacrylamide gel electrophoresis, and 
analyzing the trypsin-digested proteins by tandem mass spectrometry. 
re s u l t s: The estrogenic compounds 17β-estradiol, genistein, bisphenol A, and endosulfan pro-
duced similar protein profile changes in MCF-7 cells (phenotype: ERα+/ERβ+), but had no effect on 
MDA-MB-231 (ERα‒/ERβ+), MCF-10F (ERα‒/ERβ+), or MCF-10A (ERα‒/ERβ‒) cells. The most 
responsive proteins in MCF-7 cells were identified as histones H2A, H2B, H3, and H4. Histone 
levels were not increased in cell lines that showed no proliferative response to estrogens despite their 
rapid intrinsic growth rate in culture. 
co n c l u s i o n: Our results indicate that ER-mediated cell proliferation results in up-regulation of 
core histone proteins.
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responds to estrogenic compounds, whether 
different estrogenic chemicals act similarly 
and, if so, to identify potential common bio-
markers of effect. 
Materials and Methods
Chemicals. We obtained E2 (99% purity), 
GEN (≥ 98% purity), BPA (> 99% purity), 
and EDS (mixture of forms I and II; 99% 
purity) from Sigma-Aldrich Company Ltd 
(Gillingham, UK). Stock solutions of these 
four estrogenic compounds were prepared 
as previously described (Zhu et al. 2008b). 
Unless stated otherwise, we purchased all 
other analytical grade reagents used in this 
study from Sigma-Aldrich. 
  Cell culture. We obtained MCF-7 and 
MDA-MB-231 human breast cancer cell lines 
and MCF-10F and MCF-10A human breast 
epithelial cell lines from American Type 
Culture Collection (ATCC; East Greenwich, 
RI, USA). We cultured MCF-7 and MDA-
MB-231 cell lines in RPMI-1640 medium 
(phenol red-free) supplemented with 10% 
fetal bovine serum, 100 IU/mL penicillin, 
and 100 µg/mL streptomycin. MCF-10F and 
MCF-10A cell lines were cultured in DME/
F-12 medium containing 0.04 mM Ca2+ and 
supplemented with 0.37 g/L l-glutamine, 59 
mg/L l-leucine, 91 mg/L l-lysine, 17 mg/L 
l-methionine, 61 mg/L magnesium chlo-
ride, 49 mg/L magnesium sulfate, 1.2 g/L 
sodium bicarbonate, 2.5 µg/mL amphoteri-
cin B, 0.5 µg/mL hydrocortisone, 0.1 µg/
mL cholera toxin (Merck Biosciences Ltd., 
Nottingham, UK), 10 µg/mL insulin, 20 ng/
mL epidermal growth factor, and 5% horse 
serum (pretreated using chelex-100 resin; 
Bio-Rad, Hercules, CA, USA), as suggested 
by the ATCC. Cell cultures were grown 
in a humidified atmosphere with 5% CO2 
in air at 37°C. We harvested cells reaching 
60‒70% confluence and used them for the 
following studies. 
Cell proliferation assay (E-screen). The 
E-screen was performed as described previously 
(Zhu et al. 2008b), with some modifications. 
Briefly, we seeded cells into 96-well microtiter 
plates at a density of 1 × 104 cells/0.1 mL in 
each well in phenol red-free RPMI-1640 or 
DME/F12 medium, as appropriate, before 
treatment with the estrogenic compounds. 
Each treatment comprised six replicates. We 
performed curve fitting of each set of concen-
tration‒response data and calculations of the 
lowest effective concentration that produced 
maximal response (ECmax), the effective con-
centration that produced 50% of maximal 
response (EC50), and the highest effective 
concentration that produced no measurable 
response (ECmin) values of each of the estro-
genic compounds as described previously 
(Zhu et al. 2008b). In some instances, we 
assessed effects on cell viability by trypan blue 
exclusion, as described previously (Thatcher 
et al. 2000). 
SELDI-TOF MS analysis of cells. Cells 
from each of four cell lines were seeded at 
a density of 1 × 105 cells/mL (2 mL) in 
6-well plates (four replicate wells for each 
treatment) before being exposed to estro-
genic compounds. We prepared cell lysates 
and determined total protein content using 
the bicinchoninic acid method, as previ-
ously described (Zhu et al. 2008b). Analysis 
by SELDI-TOF MS was performed using 
CM10 ProteinChip arrays (Bio-Rad) at pH 
4.0 with sinapinic acid (Fluka, Steinheim, 
Germany) as an energy absorbance matrix 
in a 96-sample bioprocessor format. We 
analyzed ProteinChip arrays using a Protein 
Biology System IIc Reader (Bio-Rad), and 
spectra using Biomarker Wizard software 
(Bio-Rad). Details of these procedures have 
been described previously (Zhu et al. 2008b).
Liquid chromatography-MS/MS. We dena-
tured, reduced, and alkylated the cell lysates and 
separated them by 1D-SDS PAGE (NuPAGE; 
Invitrogen, Paisley, UK); we stained the gel 
with Coomassie blue; excised regions of inter-
est; and decolorized, washed, dehydrated, and 
digested the proteins with trypsin (sequenc-
ing grade, Promega, Southampton, UK) at 
37°C for 18 hr, as described previously (Zhu 
et al. 2008a). Nanoflow LC-MS/MS was per-
formed using an LTQ MS (Thermo-Fisher 
Scientific, Pittsburgh, PA, USA) to analyze 
parent ions and data-dependent MS/MS 
spectra simultaneously. We identified the 
proteins using Bioworks Browser software, 
version 3.3 (Thermo-Fisher Scientific) and 
used SEQUEST to search for matches 
within the Homo sapiens Refseq protein data-
base (National Center for Biotechnology 
Information 2009). 
Immunoblotting analysis. We separated 
lysates from treated and untreated cells 
(3.25 µg protein/lane) and purified calf thy-
mus histones (0.3 µg; Roche, West Sussex, 
UK) by SDS-PAGE. Histones were then 
transferred onto nitrocellulose filters; incu-
bated with antibodies against histones H3, 
H4 (Santa Cruz Biotechnology Inc, Santa 
Cruz, CA, USA), or H2B (Watson et al. 
1995); and detected with goat anti-rabbit 
peroxidase and electrochemiluminiscence 
(ECL; GE Healthcare, Amersham, UK) 
as described previously (Edwards 2006). 
The relative intensity of the immunoreac-
tive bands was determined by densitom-
etry using an Image Station 440CF and 
1D Image Analysis software, version 3.5 
(Kodak, Rochester, NY, USA). 
Results
Concentration‒effect analysis of cell prolifera-
tion. We measured the growth of the four cell 
lines. In the absence of any estrogen, MCF-7 
cells grew relatively slowly compared with 
the other three cell lines (Table 1). However, 
in the presence of E2, the growth rate of 
MCF-7 cells increased 4-fold relative to con-
trol (Table 1). This effect was concentration 
dependent and characterized by an EC50 of   
2 pM and ECmax of 20 pM (Figure 1), 
whereas none of the other three cell lines 
were affected by E2 at concentrations up to 
Table 1. Relative rates of proliferation of various cell lines and the effect of estrogenic compounds: relative 
increase in MMT absorbance per day (mean ± SE).
  MCF-7  MDA-MB-231  MCF-10A  MCF-10F
Control  0.10 ± 0.01  0.35 ± 0.04  0.41 ± 0.02  0.55 ± 0.05
100 pM E2  0.43 ± 0.04**  0.34 ± 0.01  0.40 ± 0.01  0.55 ± 0.03
2 µM E2  0.45 ± 0.05**  0.35 ± 0.01  0.41 ± 0.01  0.53 ± 0.03
1 µM GEN  0.45 ± 0.04**  0.34 ± 0.01  0.43 ± 0.01  0.59 ± 0.01
1 µM BPA  0.43 ± 0.05**  0.35 ± 0.01  0.41 ± 0.01  0.56 ± 0.02
10 µM EDS  0.32 ± 0.01**  0.36 ± 0.01  0.40 ± 0.01  0.34 ± 0.01*
We seeded cells into 96-well plates, and the relative rates of linear growth in the absence or presence of estrogenic com-
pounds were determined using the E-screen assay at daily intervals. Results are expressed as relative absorbance values 
per day in culture. MCF-7 and MDA-MB-231 cells were cultured for 6 days, MCF-10A cells for 5 days, and MCF-10F cells 
for 4 days according to the characteristics of each of the four cell lines (n = 3 in each case).
*p < 0.05 and **p < 0.01, compared with control (vehicle-treated) by Student’s t-test.
Figure 1. Concentration–effect curves for four 
estrogenic compounds on the proliferation rate of 
MCF-7 cells. Microtiter-plate wells were seeded 
with 10,000 MCF-7 cells per well (0.1 mL) and cul-
tured for 6 days in the presence of E2, GEN, BPA, 
EDS, or vehicle alone. After 6 days, we estimated 
the relative cell number as described in the text 
and expressed them as a percentage of the maxi-
mal response of E2. Each point represents the mean 
± SE of six determinations, and data were fitted to 
sigmoid concentration–effect curves. 
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2 µM (Table 1). The growth rate of MCF-7 
cells also increased 4-fold by treatment with 
GEN and BPA and 3-fold by EDS relative to 
control (Table 1). However, GEN and BPA 
were more than four orders of magnitude less 
potent and EDS was six orders of magnitude 
less potent than E2. Both GEN and BPA had 
ECmax values of 1 µM (Figure 1), although 
the maximum responses were similar to that 
found for E2. A full concentration‒effect 
curve for EDS was not possible, as the com-
pound was cytotoxic above 10 µM; this com-
pound was similarly cytotoxic to MCF-10F 
cells but not the other two cell lines. GEN, 
BPA, and EDS did not cause MDA-MB-231, 
MCF-10F, or MCF-10A to increase their 
growth rate (Table 1). 
SELDI-TOF MS protein profiles. 
Protein profiling by SELDI-TOF MS was 
performed on MCF-7 cells treated sepa-
rately with 20 pM E2, 1 µM GEN, 1 µM 
BPA, and 10 µM EDS. We used the con-
centrations that produced a maximal pro-
liferative response in the cells. Each of the 
test compounds produced a change in the 
protein profile of the cells, and the changes 
were similar for all the test compounds, as 
described previously (Zhu et al. 2008b). In 
all, from approximately 100 peaks detected, 
we found 12 protein ions with m/z values of 
4,128, 5,610, 6,160, 6,845, 7,010, 7,620, 
11,260, 11,426, 11,680, 13,680, 14,020, and 
15,260 that increased in intensity with treat-
ment with each of the four estrogenic com-
pounds (Figure 2). Other proteins detected 
by SELDI-TOF MS did not vary significantly 
between the untreated and treated groups. 
Among the 12 responsive ions, 8 appeared 
to be four pairs of doubly charged and sin-
gly charged ions from the same proteins, 
that is, m/z 5,610 and 11,260; m/z 6,845 
and 13,680; m/z 7,010 and 14,020; and m/z 
7,620 and 15,260.
Subsequently, MCF-7 cells were treated 
with a series of different concentrations of 
E2, GEN, BPA, and EDS to examine levels 
of these protein ions. Changes in the levels of 
these eight ions were concentration dependent 
with each of the four estrogenic compounds 
examined [see Supplemental Material, Figure 
1 (available online at http://www.ehponline.
org/members/2009/0800109/suppl.pdf)]; EC50 
values determined from these data showed that 
the response to the compounds was similar to 
that assessed by measurement of cell prolifera-
tion (Table 2). 
SELDI-TOF MS protein profiles were 
also obtained using the other three cell lines 
after treatment with 20 pM E2, 1 µM BPA, 
1 µM GEN, 10 µM EDS, and vehicle. 
Although spectra containing numerous peaks 
were obtained with each of the cell lines, 
no changes in the protein profiles, or in any 
individual peak, were found after treatment 
with E2 (Figures 2C‒2H) or any of the other 
compounds tested. Interestingly, although the 
spectra obtained for the different cell lines var-
ied somewhat, ions with m/z 11,260, 13,680, 
14,020, and 15,260 identified as potential 
biomarkers in treated MCF-7 cells were also 
present in these cell lines (Figure 2). 
Identification of responsive protein ions. 
Whole-cell preparations of MCF-7 cells 
treated with either 20 pM E2 or vehicle were 
subjected to 1D SDS-PAGE. The stained gel 
shows that the overall protein compositions 
of the two preparations were similar except 
for an increase in the intensity of bands of 
approximately 12 and 17 kDa (Figure 3). The 
lane containing the E2-treated MCF-7 cell 
proteins was sliced into five sections over the 
region equivalent to 5‒20 kDa corresponding 
to the likely masses of the proteins detected by 
SELDI-TOF MS and including bands with 
increased intensity. Each slice was subjected 
to trypsin digestion to hydrolyze the proteins 
into peptides, and then these were analyzed by 
LC-MS/MS. 
Proteins identified on the basis of at least 
four detected peptides are listed in Figure 3 
[for further details see Supplemental Material, 
Table 1 (available online at http://www.
ehponline.org/members/2009/0800109/
suppl.pdf)]. All of the core histone proteins 
Figure 2. Protein profiles of various cell lines varying in their ER phenotype. SELDI-TOF MS analysis was 
performed on (A) vehicle-treated and (B) 20 pM E2-treated MCF-7 cells; (C) vehicle-treated and (D) 20 pM 
E2-treated MDA-MB-231 cells; (E) vehicle-treated and (F) 20 pM E2-treated MCF-10A cells; and (G) vehicle-
treated and (H) 20 pM E2-treated MCF-10F cells. A number of protein ions identified as possible biomarkers 
in MCF-7 cells were also prominent in the spectra of the other cell lines and are indicated by arrows. In 
each case, treatment of cells with 1 μM GEN, 1 μM BPA, and 10 μM EDS produced similar profiles to those 
obtained after treatment with 20 pM E2.
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were represented (i.e., histones H2A, H2B, 
H3, and H4). Histone H4 was the only pro-
tein identified in slice 3 of the gel, equiva-
lent to the 12 kDa band. Histone H2A 
occurred in slice 4 along with three other 
proteins. Both histones H2B and H3, as 
well as seven other proteins, were detected 
in slice 5. Protein masses determined by 
SELDI-TOF MS were accurate to within 
0.3%. The masses of each of the core his-
tones were within this error of measurement. 
None of the other proteins identified by 
LC-MS/MS had masses within 0.3% of the 
major peaks in the SELDI-TOF MS spectra 
[Figure 3; see Supplemental Material, Table 
1 (available online at http://www.ehponline.
org/members/2009/0800109/suppl.pdf)]. 
Additional analyses were performed with the 
same samples on cation-exchange chips at pH 
7 and 9 (data not shown). The intensities of 
the protein ions corresponding to the ions of 
interest were similar at pH 7 to those obtained 
at pH 4. They were also clearly detectable 
at pH 9, albeit with slightly reduced inten-
sity, suggesting that the ions were from highly 
basic proteins. Histones were the most basic 
proteins detected in the SDS-PAGE gel 
[see Supplemental Material, Table 1 (avail-
able online at http://www.ehponline.org/
members/2009/0800109/suppl.pdf)], further 
supporting their identification.
To investigate the identity of these proteins 
further, purified preparations of the core his-
tones were obtained and analyzed by SELDI-
TOF MS under the same conditions as those 
used to analyze the MCF-7 cell preparations 
(Figure 3). The histones used were from calf 
thymus; the sequences of human histones are 
identical or extremely similar to bovine his-
tones (Marino-Ramirez et al. 2006). All of 
the core histones were readily detected and 
each was detected as both singly charged and 
doubly charged species, that is, [M+H]+ and 
[M+2H]2+ ions, respectively. In each case, 
the singly charged ion was more intense than 
the respective doubly charged ion. All of the 
ions corresponded to peaks detected using 
E2-treated MCF-7 cells (Figure 3). 
Some additional peaks were detected in 
the spectra of each of the purified histones. 
These included slightly higher mass spe-
cies, most evident as shoulders on the main 
[M+H]+ peaks, but also apparent as smaller 
[M+2H]2+ peaks. This was particularly notice-
able in the spectra of histones H4 and H2B. 
For histone H4, ions with m/z 11,426 and 
Table 2. Comparison of EC50 (mean ± SE) values for estrogenic compounds on MCF-7 cells determined by 
measurement of cell proliferation and SELDI-TOF MS protein ion intensity. 
Parameter  E2 (pM)  GEN (nM)  BPA (nM)  EDS (µM)
Cell proliferation  2.4 ± 0.7  40.7 ± 1.7  158 ± 51  2.5 ± 0.2
m/z 5,610 ion  2.6 ± 0.3  46.9 ± 7.0  155 ± 19  2.0 ± 0.1
m/z 6,845 ion  2.2 ± 0.3  45.1 ± 7.7  143 ± 14  2.4 ± 0.4
m/z 7,010 ion  2.3 ± 0.5  52.9 ± 7.8  149 ± 37  2.3 ± 0.4
m/z 7,620 ion  2.6 ± 0.3  47.6 ± 7.0  139 ± 23  1.9 ± 0.4
m/z 11,260 ion  2.3 ± 0.7  54.5 ± 15.3  144 ± 33  1.8 ± 0.4
m/z 13,680 ion  2.2 ± 0.6  52.8 ± 14.6  155 ± 39  2.1 ± 0.6
m/z 14,020 ion  2.6 ± 1.0  52.8 ± 3.0  176 ± 31  2.1 ± 0.2
m/z 15,260 ion  2.5 ± 0.3  42.0 ± 5.0  176 ± 20  2.0 ± 0.2
EC50 values were determined from concentration–effect data by curve fitting using a four-parameter sigmoidal model 
by nonlinear regression. SEs were calculated from replicate experiments (n = 3). No significant differences between the 
values obtained by the cell proliferation method or the intensities of the ions determined by SELDI-TOF MS were found for 
any of the compounds.
ap > 0.05 in all cases by Student’s t-test.
Figure 3. Identification of responsive protein ions. (A) Coomassie blue–stained SDS-polyacrylamide gel of whole-cell protein extracts of MCF-7 cells treated with 
20 pM E2 and vehicle (V). Molecular weight markers are shown on the left-hand side. The lane containing the E2-treated cells was divided as shown, and the pro-
teins in each slice of the gel were digested with trypsin in preparation for analysis by LC-MS/MS. The identified proteins found in each slice of the gel are listed 
along with the predicted molecular weight of each protein. (B) Comparison of SELDI-TOF mass spectra of estrogen-responsive protein ions in MCF-7 cells and 
purified histones. (a) 20 pM E2-treated MCF-7 cells. The 12 estrogen-responsive protein ions identified are indicated. Purified preparations of calf thymus histones 
were analyzed under similar conditions with 0.1 µg each of histones (b) H3, (c) H2B, (d) H2A, and (e) H4. The major ions evident in each spectrum are indicated 
along with their likely charge state. 
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m/z 11,680 were present as overlapping peaks 
forming a shoulder of the main m/z 11,260 
ion. Singly and doubly charged species of all 
of these ions appeared to be present in the 
spectra of MCF-7 cells. Also, a collection of 
small peaks was present in the spectrum of 
histone H4 with m/z 12,180–12,360. Ions 
with m/z 6,160 and m/z 4128 apparent in the 
MCF-7 cell spectra may represent doubly and 
triply charged species of this protein. A similar 
distribution of peaks was also seen in the spec-
tra of histone H2B, in this case with an ion 
m/z 13,898 forming a shoulder of the main 
m/z 13,680 peak and several smaller peaks 
such as those with m/z 14,646. Although 
no distinct separate peaks were identified in 
the corresponding regions of the spectra of 
histones H2A and H3, the shapes of these 
peaks were distorted toward higher masses, 
suggesting that species with increased masses 
were also present in these preparations. These 
species probably represent post-translational 
modifications of the proteins, for example, 
by acetylation, methylation, phosphorylation, 
which occur commonly in histones, as well 
as variant forms of the histones. Such species 
were also apparent in the cell preparations, 
but were difficult to quantify as they did not 
form discrete peaks. Thus, the identity of all 
12 of the responsive protein ions could be 
ascribed to histones or their posttranslation-
ally modified forms.
Western blotting of histones. Up-regulation 
of histones H2B, H3, and H4 in MCF-7 cells 
treated with E2 was demonstrated in a previ-
ous study by immunoblotting (Zhu et al. 
2008a). These effects are compared here with 
those of GEN, BPA, and EDS (Table 3). All 
four compounds had similar effects on histone 
protein levels. Results were consistent with those 
obtained using SELDI-TOF MS (Table 3).
Comparative levels of histone H2B were 
determined in all four cell lines used here. 
Constitutive levels in MDA-MB-231 cells were 
similar to those in MCF-7 cells, whereas levels 
in MCF-10A and MCF-10F cells were only 
about 50% of those in MCF-7 cells (Table 4). 
Treatment with E2 affected H2B expression 
only in MCF-7 cells; levels were unchanged in 
the other three cell lines (Table 4).
Discussion
The ability of E2 to stimulate the prolifera-
tion of MCF-7 cells is well established 
(Katzenellenbogen et al. 1987). This is accom-
panied by a number of cellular changes that 
have been investigated most comprehensively 
at the level of gene expression (Buterin et al. 
2006; Frasor et al. 2003), although a number 
of alterations at the protein level have also been 
demonstrated (Zhu et al. 2008a). Here, we 
investigated the effect of E2 on the whole-cell 
protein profile using SELDI-TOF MS. It was 
evident that treatment with E2 had a profound 
upregulatory effect on a number of protein ions 
detectable by this technique. The minimum 
concentration of E2 that produced a maximal 
response of the protein ions in MCF-7 cells was 
20 pM, and this is similar to that determined 
using the E-Screen assay on these cells. This 
value for E-Screen is consistent with that found 
in several previous studies, which report similar 
ECmax values for E2 in the range of 10‒20 pM 
(Soto et al. 1995; Suzuki et al. 2001; Villalobos 
et al. 1995), although a higher value of 80‒100 
pM was reported by Coser et al., and a value 
in the range of 50‒200 pM can be deduced 
from the data shown in Rajapakse et al. (2004). 
Albeit less potent than E2, GEN, BPA, and 
EDS also increased the proliferation rate 
of MCF-7 cells, as found in previous studies 
(Soto et al. 1994; Wang et al. 1996; Zhu et al. 
2008b) and resulted in protein profile changes 
similar to those produced by E2. E2, GEN, and 
BPA have previously been reported to produce 
similar effects on the expression of a number of 
genes in both MCF-7 cells and the developing 
female rat reproductive system (Buterin et al. 
2006; Dip et al. 2008; Naciff et al. 2002). All 
the other cell lines studied here lacked expres-
sion of ERα, and none of them showed changes 
in either proliferation rate or in protein profile 
after treatment with any of the estrogenic com-
pounds. Thus, these data are consistent with the 
concept that ERα (or ERα/ERβ heterodimer) 
in MCF-7 cells plays a controlling role in the 
response to estrogenic compounds (Ter Veld 
et al. 2006). It was apparent that ERβ alone 
did not facilitate any response, at least for the 
compounds examined here. In other studies 
(Zhu et al. 2008b), we have shown that none of 
the compounds affected the response to others 
in MCF-7 cells, suggesting that ERα response 
is not modified by any effect on ERβ. GEN 
and BPA appear to bind more strongly to ERβ 
than ERα (Kuiper et al. 1997) and so might 
exert a greater effect via ERβ. It is possible that 
compounds with a greater affiity for ERβ may 
produce effects other than those found here. 
The principal feature of the SELDI-TOF 
MS protein profile changes in MCF-7 cells 
after estrogen treatment was an increase in the 
levels of core histone proteins. Histone pro-
teins are a group of relatively small basic pro-
teins with masses in the range of 11‒15 kDa 
and isoelectric points (pIs) > 10. The ready 
detection of such proteins by SELDI-TOF MS 
is consistent with the conditions used. Basic 
proteins would be expected to bind strongly 
to the cation exchange interactive surface at 
pH 4, and proteins in the range of 5‒20 kDa 
are particularly well suited to detection by 
SELDI-TOF MS (Petricoin and Liotta 2004). 
Up-regulation of these core histones is also 
supported by immunodetection and a label-
free quantitative LC-MS/MS approach used 
to examine the differentially expressed proteins 
in E2-treated MCF-7 cells (Zhu et al. 2008a). 
Previously, microarray and RT-PCR analysis 
of MCF-7 cells treated with 100 pM E2 for 24 
hr was reported to cause up-regulation of his-
tone H2A genes (members X and Z), although 
in the same study a decrease in the expression 
of histone 1 H2ac and H2BE genes was also 
reported (Buterin et al. 2006). In contrast, no 
variation in mRNA levels of histones in the 
developing female reproductive system of rats 
treated with 17α-ethynyl estradiol (Naciff et al. 
2002) was reported. Histone proteins are core 
components of nucleosomes. A nucleosome is 
composed of an octamer of histone proteins 
comprising two molecules each of histones 
Table 4. Comparative levels of histone H2B in each of the four breast-derived cell lines. 
  Relative histone H2B level
Cell line  Control cells  E2-treated cells
MCF-7  1.00 ± 0.06  2.30 ± 0.11**
MDA-MB-231  1.18 ± 0.10  1.22 ± 0.02 
MCF-10A  0.52 ± 0.02**  0.51 ± 0.03 
MCF-10F  0.41 ± 0.05**  0.43 ± 0.07 
NS, not significant. The levels relative to total cell protein and normalized to those measured in vehicle-treated MCF-7 
cells were determined by immunoblotting in each of control (vehicle-treated) cells and cells treated with 20 pM E2. 
**p < 0.01 compared with control (vehicle-treated) MCF-7 cells by Student’s t-test. 
Table 3. Relative levels of histone proteins in MCF-7 cells after treatment with estrogenic compounds. 
  Relative histone level (mean ± SE, n = 4)
  H2A  H2B    H3    H4
Treatment  SELDI  SELDI  IB  SELDI  IB  SELDI  IB
E2  2.3 ± 0.6   2.1 ± 0.3   2.3 ± 0.1  3.1 ± 0.3  2.9 ± 0.2  2.1 ± 0.4   2.6 ± 0.1
GEN  2.2 ± 0.3  2.2 ± 0.6   2.2 ± 0.2  2.5 ± 0.4  2.6 ± 0.3  2.1 ± 0.4   2.8 ± 0.3
BPA  2.1 ± 0.5   2.1 ± 0.1   2.2 ± 0.1  2.6 ± 0.3   2.2 ± 0.2  2.1 ± 0.2   2.7 ± 0.4
EDS  2.3 ± 0.2  2.0 ± 0.5   2.4 ± 0.1  2.4 ± 0.2   2.8 ± 0.2  2.2 ± 0.6   2.6 ± 0.2
We treated cells with 20 pM E2, 1 µM GEN, 1 µM BPA, or 10 µM EDS for 6 days, and compared the levels of histones with 
those of vehicle-treated cells by SELDI-TOF MS (SELDI) and immunoblotting (IB). Immunoblotting data was not obtained 
for histone H2A, as no suitable antibody was available. Both methods performed similarly; there were no statistically 
significant differences between levels of histones determined by SELDI-TOF MS or immunoblotting. p > 0.05 in all cases 
by Student’s t-test.Expression of histone during cell proliferation
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H2A, H2B, H3, and H4. Nucleosomes pro-
vide a structure around which DNA is coiled 
and allow formation of compacted higher 
ordered structures, that is, chromatin. DNA 
accessibility is regulated via a complex set of 
post-translational modifications of the highly 
conserved core histones H2A, H2B, H3, and 
H4 such as acetylation, methylation, phospho-
rylation, ubiquitination, and ADP-ribosylation 
(Bartova et al. 2008; Bonisch et al. 2008).
In this way, histones can regulate gene 
expression, as well as cell growth and prolifera-
tion (Jenuwein and Allis 2001). Up-regulation 
of all the core histones H2A, H2B, H3, and 
H4 to the same extent as found in this present 
study, may represent an increase in the chroma-
tin content of cells and appears consistent with 
the mitogenic effect of E2 on MCF-7 cells.
It was evident that changes in the levels 
of core histones mirrored the degree of prolif-
eration induced by each of the four estrogenic 
compounds. Concentration–effect curves pro-
duced on the basis of relative intensity of ions 
representing each of the singly charged his-
tones were quantitatively similar to those for 
cell proliferation. This might suggest that his-
tone protein levels are simply indirect markers 
of cell proliferation; indeed, up-regulation 
of histone mRNA levels as a cell prolifera-
tion marker is well documented (Bosch et al. 
1993; Muskhelishvili et al. 2003; Slowinski 
et al. 2005). However, although the cell lines 
investigated here were insensitive to E2, GEN, 
BPA, and EDS, they still grew rapidly while 
expressing relatively low levels of histone pro-
teins. In fact, the rate of growth of MCF-10F 
cells exceeded that of E2-stimulated MCF-7 
cells, and yet among the cell lines examined, 
this one contained the lowest levels of histone 
proteins. Hence, histone protein levels do not 
appear to reflect the rate of cell proliferation 
as do mRNA levels. On the basis of these 
results, it would appear possible that core his-
tone proteins might serve as biomarkers of 
ER-mediated cell proliferation. This hypothe-
sis warrants further investigation using a vari-
ety of other estrogen-sensitive and -insensitive 
cells, including those of primary origin.
In summary, using proteomic profiling by 
SELDI-TOF MS, it was possible to identify 
a number of protein ions that varied on treat-
ment of MCF-7 cells with a variety of struc-
turally diverse estrogenic compounds. These 
changes reflected mainly up-regulation of 
histones H2A, H2B, H3, and H4 after ERα 
activation. It is possible that up-regulation 
of core histones is selectively indicative of 
ER-mediated cell proliferation. 
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